Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 11Melanoma 4Neoplasm Metastasis 3Colorectal Neoplasms 3Thyroid Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Hematologic Neoplasms 2Glioma 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Solid Tumor 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Noonan Syndrome 5 1Neurofibromatosis 1 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Hereditary Sensory and Autonomic Neuropathies 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1

Interventions

glutathione pegylated liposomal doxorubicin 1binimetinib 1Trastuzumab 1PF-07284890 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × binimetinib × Thoracic × Clear all
NCT04543188 2025-10-23

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Pfizer

Phase 1 Terminated
65 enrolled 52 charts
CNSDermatologicThoracic

Brain Diseases, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡